Crossmark

HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo

Published Online: 2024-05-03

Authors

Li, Xueying

Zhao, Lifen

Li, Wenzhe

Gao, Peng

Zhang, Nianzhu http://orcid.org/0000-0001-7140-2419
Funding

Funding for this research was provided by:

Natural Science Foundation of Liaoning Province (2022-BS-254)

National Natural Science Foundation of China (32171279)
License Information

Text and Data Mining valid from 2024-05-03

Version of Record valid from 2024-05-03
More Information

Article History

Received: 4 February 2024

Revised: 16 April 2024

Accepted: 22 April 2024

First Online: 3 May 2024

Competing interests

: The authors declare no competing interests.

Document is current